According to the latest scientific paper published in “Cell Death & Differentiation” it is recommended to administer vitamin B3 as a dietary supplement in coronavirus infection. Dietary supplements based on vitamin B3 derivative are produced by Pharmena.
Vitamin B3 against COVID-19
The scientific publication of March 2020, prepared by a group of Chinese and Italian scientists, indicates that vitamin B3 (niacin or nicotinamide) may be one of the elements in the treatment of COVID-19 infection. The main metabolite of vitamin B3 is 1-MNA. The published paper provides a reference point for Pharmena to further analyse and consider the potential concept of 1-MNA for the treatment of coronavirus effects.
Pharmena ratings up
Pharmena’s quotations on Thursday went up by almost 40% and reached the highest level since October 2019, Puls Biznesu informed. This is due to the fact that the company bases its business on the production of dietary supplements containing the 1-MNA particle. It is a patented derivative (metabolite) of vitamin B3.
1-MNA is the basic component of Menavitin brand dietary supplements currently available in the company’s portfolio. Particle 1-MNA has been registered by the European Food Safety Authority (EFSA) as a new category of food ingredients.